Adlai Nortye Group Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
109
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Adlai Nortye Group Ltd. - ADR market cap is $502.18M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Adlai Nortye Group Ltd. - ADR 52 week high is $17.25 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Adlai Nortye Group Ltd. - ADR 52 week low is $0.8786 as of November 22, 2026.
Adlai Nortye Group Ltd. - ADR stock price today is $8.55.
Adlai Nortye Group Ltd. - ADR stock price yesterday was $9.06.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Adlai Nortye Group Ltd. - ADR's P/E ratio is -15.75.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Adlai Nortye Group Ltd. - ADR P/B ratio is 2.5629.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Adlai Nortye Group Ltd. - ADR 50-day moving average is $12.43.